July 15, 2016 |
In the biggest effort yet to find a cure for HIV, the National Institutes of Health on Wednesday named six large scientific teams, one led by Philadelphia's Wistar Institute and the University of Pennsylvania, to tackle different parts of the challenge. The government will commit $30 million a year for five years to the project. The Philadelphia collaboration will get $4.6 million a year. For years, with the world focused on getting treatment to millions of infected people and preventing further spread of the disease, the notion of a "cure seemed naive and overambitious," said Luis J. Montaner, the director of an HIV laboratory at Wistar, who will share leadership of the Philadelphia team.
July 3, 2016 |
Joe Tarrant's family had plenty of reasons to worry about him. Complications during his birth left him developmentally disabled. By the time he was 5, doctors discovered that only one of his kidneys was fully functional. Decades of wear on his healthy kidney ultimately destroyed that organ. By age 40, he required a kidney transplant. Still, Joe led a full life, including lots of outdoor activities. "His kidney was fine. His heart was fine," big brother Patrick Tarrant, who lives in Newtown, recalled recently.
July 2, 2016 |
University of Pennsylvania researchers have earned acclaim in recent years for using a type of genetic engineering to treat leukemia. Now another Penn team says the tactic may be effective against a debilitating skin disease. That is because the two maladies have something in common: deviant cells of the immune system. The treatment for the skin disease, a rare autoimmune disorder called pemphigus vulgaris, has been demonstrated so far only in mice, the scientists reported online Thursday in the journal Science.
May 26, 2016 |
Question: I have been seeing this guy for a couple of months now. He started very fast, being very involved with me, but a few weeks later, he took a step back and said that he liked being around me, but that when he realized he was getting real feelings for me, he was scared. Now he doesn't text or ask me out every day, but we hang out once a week and call it "casual dating. " Although I like the casualness of it and not having to report to someone every moment of my day, I also don't want us to just "hook up. " It feels cheap.
February 24, 2016 |
Formula Pharmaceuticals Inc., of Berwyn, and Rockland Immunochemicals Inc., in Limerick, announced a collaboration Monday to develop cancer immunotherapies, focusing on Formula's Cytokine Induced Killer (C.I.K.) cell-based chimeric antigen receptor (CAR) technology to treat cancer. Financial terms were not disclosed. Rockland will provide the research staff and a 60,000-square-foot research and development facility to develop and increase Formula's product pipeline, Formula president and CEO Maurits W. Geerlings said.
February 12, 2016 |
How close are we to THE ULTIMATE healing factor? As "Deadpool" explodes across the big screen this weekend, the antihero with extraordinary healing powers-that save him from everything from cancer to bullets - is not THAT far-fetched, according to renowned physician, and North Philadelphia native, Dr. Ronald Klatz . The author of 42 books including the bestseller Grow Young With HGH , Klatz is a bioscientist with a portfolio of dozens...
January 17, 2016 |
Vice President Biden met with scientists at the University of Pennsylvania's Abramson Cancer Center Friday afternoon, officially launching his "moonshot" quest to cure cancer. "We're on the cusp of phenomenal breakthroughs," Biden said, adding that President Obama would be issuing an executive order that would get every federal agency involved in the effort. Biden asked the researchers to educate him on the challenges and possibilities of genome-based discoveries of the last several years, particularly a type of immunotherapy that has been pioneered by Penn researcher Carl H. June.
January 4, 2016 |
What will 2016 bring in the way of medical advances? As president and CEO of Philadelphia's University City Science Center, an incubator of medical research, Stephen Tang has an uncommon vantage point on that question. He predicts gene therapy, an experimental technique that uses genes to treat or prevent disease, and health information technology will boom this year. He spoke to us recently about the center and what lies ahead. Tell us more about the Science Center.
November 19, 2015 |
When it comes to a still-mysterious condition known as Castleman disease, David Fajgenbaum, a professor of hematology/oncology at the University of Pennsylvania's Perelman School of Medicine, is more than an advocate or a physician/scientist: He is also a patient. Addressing a team of volunteers for the Castleman Disease Collaborative Network (CDCN), Fajgenbaum quickly details on a white board what is known about CD, a group of poorly understood inflammatory disorders that can vary from a single enlarged lymph node to life-threatening multiple organ failure.
April 19, 2015 |
Horses pull carts, jump hurdles, and carry everyone from jockeys to preteen girls. They are pretty good on their feet. So when a horse falls for no apparent reason, people notice. That's what happened three years ago to Ranger, a retired Thoroughbred racehorse living at Manor College's Jenkintown campus. "The students kept telling me that he would fall asleep suddenly and almost fall down before catching himself," said veterinarian Amy Bentz, an adjunct professor who teaches large-animal courses in Manor's Veterinary Technology Program.